Dr. Daniel Buchen, MD

Dr. Buchen practices at Maimonides Medical Center in Brooklyn, New York, part of Maimonides Medical Center.

Dr. Buchen's NPI, 1922069467, was assigned on March 31, 2006. Dr. Buchen graduated from SUNY Downstate Health Sciences University in 1994. Dr. Buchen holds New York license 210228.

Dr. Buchen's primary practice is Maimonides Medical Center, at 4802 Tenth Avenue, Brooklyn, NY 11219 in Kings County. The practice phone is (718) 283-6000.

Dr. Buchen's primary practice is Maimonides Medical Center in Brooklyn, New York, part of Maimonides Medical Center. The medical group on file is Maimonides Medical Center. Dmand AI also links Dr. Buchen to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buchen practices. Vendor and product names are available with a free account.

Dermatology is Dr. Buchen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Buchen is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Buchen's licenses on file in 3 states: New York, California and New Jersey.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, joint cyst, minor injury on trunk, minor injury to a limb and psoriasis among the conditions Dr. Buchen treats.

CMS data shows 770 Medicare services from Dr. Buchen across 11 procedure codes in 2024, for 340 Medicare patients. Medicare paid $70,972 for them. Every service was in an office.

CMS counts 340 Medicare patients who saw Dr. Buchen in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buchen's median patient age at 58, with 54% women.

In 2024, Dr. Buchen wrote 499 Medicare Part D claims for 257 patients. 89% of them were for generic drugs. CMS names the drug for 400 of them, across 9 drugs with 11 or more claims each, at $90,791 in total drug cost. In 2023, CMS named 251 claims across 6 drugs.

Dr. Buchen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of melanoma (skin cancer) excision by Dr. Buchen, more than 78% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Buchen. The most frequent topics are Circadian Rhythm, Dietary Carbohydrates and Rats, Inbred Strains.

CMS Open Payments shows 66 general payments to Dr. Buchen from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 90% of the total. Sanofi and Genzyme US Companies paid the most, $18,047.

Dmand AI lists 3 awards for Dr. Buchen, most recently AAD Fellow in 2012.

Dr. Buchen graduated from SUNY Downstate Health Sciences University in 1994. Dr. Buchen is a member of AAD.

Dr. Buchen is in network with 16 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.